The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Progress of Targeted Therapy for Non-Small Cell Lung Cancer
Author(s): 
Pages: 42-44
Year: Issue:  4
Journal: China Prescription Drug

Abstract:  肺癌的发病率和死亡率在全球恶性肿瘤中居首位.其中,非小细胞肺癌(NSCLC)占80%~85%.绝大多数NSCLC临床确诊时处于复发或转移性的晚期阶段,化疗是这部分人群的主要治疗手段.
Related Articles
loading...